Objectives: This systematic review aims to assess and explore various determinants of cancer- related fatigue. Methods: A systematic search of various determinants of Cancer-related fatigue (CRF) was performed in different databases like PubMed, Google Scholar, Science Direct and Clinical Key dating from 1990 to September 2020. Results: A total of 6115 studies were screened and 95 articles related to determinants of fatigue were retained. Various modifiable and non-modifiable determinants including socio-demographic, clinical, treatment related, plasma biomarker related, genetic, behavioural, concurrent symptoms related and psychological determinants were identified. Depression was one of the significant factors reported in 28% of studies, followed by pain, (17%), performance status (16%), chemotherapy and anxiety (15%). Conclusion: It is recommended that nurses and clinicians should anticipate, identify and take appropriate interventions to manage those modifiable factors. Ultimately, managing the modifiable factors helps in the comprehensive care of cancer patients.
IrvineDVincentLGraydonJEBubelaNThompsonL. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs. 1994;17(5):367–378. Accessed on December 26, 2020.
CellaDPetermanAPassikSJacobsenPBreitbartW. Progress toward guidelines for the management of fatigue. Oncology (Williston Park). 1998;12(11A):369–377. Accessed on December 28, 2020.
4.
ServaesPVerhagenCBleijenbergG. Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27–43. Accessed on January 01, 2021.
5.
CellaDDavisKBreitbartWCurtGCoalitionF. Cancer related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385–3391. Accessed on December 26, 2020.
6.
JavethASilvaFDSinghP. Myriad of cancer related fatigue: A concept model on multifactorial causation and impact. Indian J Palliat Care. 2021;27(2):354–356. Accessed on September 10, 2021.
7.
HuttonBSalantiGCaldwellDM, et al.The prisma extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med. 2015;162(11):777–784. Accessed on December 30, 2020.
8.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. Accessed on December 25, 2020.
9.
Joanna Briggs Institute (JBI) Critical appraisal tools. South Australia: The University of Adelaide; 2018. https://jbi.global/critical-appraisal-tools. Accessed on September 28, 2021.
10.
AmielCRFisherHMAntoniMH. Concerns about breast cancer, pain, and fatigue in non-metastatic breast cancer patients undergoing primary treatment. Healthcare (Basel). 2016 Aug 26;4(3):62. Accessed on December 28, 2020.
11.
AndersonKOGettoCJMendozaTR, et al.Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr;25(4):307–318. Accessed on December 28, 2020.
12.
AntolínRAMartínez-PiñeiroLJiménez RomeroME, et al.Prevalence of fatigue and impact on quality of life in castration-resistant prostate cancer patients: The vital study. BMC Urol. 2019;19(1):92. Accessed on December 26, 2020.
13.
ArrietaOMichel OrtegaRMVillanueva-RodríguezG, et al.Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: A prospective study. BMC Cancer. 2010 Feb 21;10:50. Accessed on December 26, 2020.
14.
Balderas-PeñaLMGonzález-BarbaFMartínez-HerreraBE, et al.Body composition and biochemical parameters of nutritional status: Correlation with health-related quality of life in patients with colorectal cancer. Nutrients. 2020 Jul 16;12(7):2110. Accessed on January 01, 2021.
15.
BarkerCLRoutledgeJAFarnellDJSwindellRDavidsonSE. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer. 2009 May 19;100(10):1558–1565. Accessed on January 02, 2021.
16.
BerendesDKeefeFJSomersTJKothadiaSMPorterLSCheavensJS. Hope in the context of lung cancer: Relationships of hope to symptoms and psychological distress. J Pain Symptom Manage. 2010 Aug;40(2):174–182. Accessed on December 26, 2020.
17.
BergerAMFarrLAKuhnBRFischerPAgrawalS. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage. 2007 Apr;33(4):398–409. Accessed on December 28, 2020.
18.
BowerJEGanzPAIrwinMRCastellonSArevaloJColeSW. Cytokine genetic variations and fatigue among patients with breast cancer. J Clin Oncol. 2013 May 1;31(13):1656–1661. Accessed on December 30, 2020.
19.
CarlsonLEGarlandSN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12(4):278–285. Accessed on December 29, 2020.
20.
Karakoyun-CelikOGorkenISahinSOrcinEAlanyaliHKinayM. Depression and anxiety levels in woman under follow-up for breast cancer: Relationship to coping with cancer and quality of life. Med Oncol. 2010 Mar;27(1):108–113. Accessed on December 26, 2020.
21.
CharalambousAGiannakopoulouMBozasEPaikousisL. Parallel and serial mediation analysis between pain, anxiety, depression, fatigue and nausea, vomiting and retching within a randomised controlled trial in patients with breast and prostate cancer. BMJ Open. 2019 Jan 24;9(1):e026809. Accessed on January 01, 2021.
22.
ChenJLiWCuiL, et al.Chemotherapeutic response and prognosis among lung cancer patients with and without depression. J Cancer. 2015 Sep 15;6(11):1121–1129. Accessed on December 27, 2020.
23.
YangTFWongTTChengLY, et al.Neuropsychological sequelae after treatment for medulloblastoma in childhood--the Taiwan experience. Childs Nerv Syst. 1997 Feb;13(2):77–80. Accessed on December 29, 2020.
24.
CourtierNGamblingTBarrett-LeePMasonMD. Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy. Adv Radiat Oncol. 2018 May 31;3(4):552–558. Accessed on December 28, 2020.
25.
CourtierNGamblingTEnrightSBarrett-LeePAbrahamJMasonMD. Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer. 2013 Jan;21(1):173–181. Accessed on January 01, 2021.
26.
DahalAMehetaRK. Fatigue experience and coping strategies among cancer patients receiving chemotherapy. J Nepal Health Res Counc. 2018 Oct 30;16(3):285–290. Accessed on January 02, 2021.
27.
DavidsonJRMacLeanAWBrundageMDSchulzeK. Sleep disturbance in cancer patients. Soc Sci Med. 2002 May;54(9):1309–1321. Accessed on January 01, 2021.
28.
Delgado-GuayMYennurajalingamSParsonsHPalmerJLBrueraE. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manage. 2011 May;41(5):819–827. Accessed on December 30, 2020.
29.
DelpachitraSCampbellAWibowoE. Preference for sleep management strategies among prostate cancer patients: An Aotearoa/New Zealand perspective⋆. Cancer Treat Res Commun. 2020;25:100219. Accessed on December 27, 2020.
30.
DengSMChiuAFWuSC, et al.Association between cancer-related fatigue and traditional Chinese medicine body constitution in female patients with breast cancer. J Tradit Complement Med. 2020 Aug 31;11(1):62–67. Accessed on December 28, 2020.
31.
Ristevska-DimitrovskaGFilovIRajchanovskaDStefanovskiPDejanovaB. Resilience and quality of life in breast cancer patients. Open Access Maced J Med Sci. 2015 Dec 15;3(4):727–731. Accessed on December 26, 2020.
32.
EchteldMAPasschierJTeunissenSClaessenSde WitRvan der RijtCC. Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer. 2007 Apr;43(6):1030–1036. Accessed on December 26, 2020.
33.
EscalanteCPManzulloEFLamTPEnsorJEValdresRUWangXS. Fatigue and its risk factors in cancer patients who seek emergency care. J Pain Symptom Manage. 2008 Oct;36(4):358–366. Accessed on December 29, 2020.
34.
EshraghJDhruvaAPaulSM, et al.Associations between neurotransmitter genes and fatigue and energy levels in women after breast cancer surgery. J Pain Symptom Manage. 2017 Jan;53(1):67–84. e7. Accessed on December 27, 2020.
35.
FabiAFalcicchioCGiannarelliDMaggiGCognettiFPuglieseP. The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?Breast. 2017 Aug;34:44–52. Accessed on January 01, 2021.
36.
FangYHHsiehMJHungMS, et al.Low concentrations of dehydroepiandrosterone sulfate are associated with depression and fatigue in patients with non-small-cell lung cancer after chemotherapy. Neuropsychiatr Dis Treat. 2020 Sep 17;16:2103–2109. Accessed on December 30, 2020.
37.
FernandesRStonePAndrewsPMorganRSharmaS. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage. 2006 Sep;32(3):245–254. Accessed on December 26, 2020.
38.
FillerKLyonDMcCainN, et al.Relationship of mitochondrial enzymes to fatigue intensity in men with prostate cancer receiving external beam radiation therapy. Biol Res Nurs. 2016 May;18(3):274–280. Accessed on December 28, 2020.
39.
FreemanSHirdesJPStoleePGarciaJSmithTF. Correlates and predictors of changes in dyspnea symptoms over time among community-dwelling palliative home care clients. J Pain Symptom Manage. 2015 Dec;50(6):793–805. Accessed on December 30, 2020.
40.
SchadFThronickeAvon TrottPOeiSL. Analysis of changes in cancer-related fatigue of breast cancer patients receiving an integrative medicine program. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420963780. Accessed on January 01, 2021.
41.
FuocoDdi TomassoJBoulosC, et al.Identifying nutritional, functional, and quality of life correlates with male hypogonadism in advanced cancer patients. Ecancermedicalscience. 2015 Aug 4;9:561. Accessed on January 01, 2021.
42.
GeinitzHZimmermannFBStollP, et al.Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):691–698. Accessed on December 26, 2020.
43.
GerberLHStoutNMcGarveyC, et al.Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2011 Oct;19(10):1581–1591. Accessed on January 01, 2021.
44.
GeyerHLKosiorekHDueckAC, et al.Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL international working group. Haematologica. 2017 Jan;102(1):85–93. Accessed on December 28, 2020. Accessed on December 26, 2020.
45.
GivenCWGivenBAzzouzFKozachikSStommelM. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage. 2001 Jun;21(6):456–466. Accessed on December 30, 2020.
46.
GoedendorpMMGielissenMFVerhagenCAPetersMEBleijenbergG. Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer. 2008 Nov 4;99(9):1408–1414. Accessed on December 26, 2020.
47.
GoldsteinDBennettBFriedlanderMDavenportTHickieILloydA. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: A longitudinal study. BMC Cancer. 2006 Oct 9;6:240. Accessed on December 28, 2020.
48.
HannDMGarovoyNFinkelsteinBJacobsenPBAzzarelloLMFieldsKK. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study. J Pain Symptom Manage. 1999 May;17(5):311–319. Accessed on January 02, 2021.
49.
HervouetSSavardJSimardS,et al.Psychological functioning associated with prostate cancer: Cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. J Pain Symptom Manage. 2005 Nov;30(5):474–484. Accessed on December 28, 2020.
50.
HoferFKoinigKANaglLBorjanBStauderR. Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy. Ann Hematol. 2018 Nov;97(11):2235–2243. Accessed on December 27, 2020.
51.
HopwoodPStephensRJ. Depression in patients with lung cancer: Prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 2000 Feb;18(4):893–903. Accessed on December 27, 2020.
52.
HsiaoCPAranetaMWangXMSaliganLN. The association of IFI27 expression and fatigue intensification during localized radiation therapy: Implication of a para-inflammatory bystander response. Int J Mol Sci. 2013 Aug 16;14(8):16943–16957. Accessed on January 01, 2021.
53.
HsiaoCPReddySYChenMKSaliganLN. Genomic profile of fatigued men receiving localized radiation therapy. Biol Res Nurs. 2016 May;18(3):281–289. Accessed on January 01, 2021.
54.
HuangXZhangQKangXSongYZhaoW. Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: a cross-sectional study. BMC Cancer. 2010 Aug 23;10(453), Accessed on December 27, 2020.
55.
HusainAFStewartKArseneaultR, et al.Women experience higher levels of fatigue than men at the end of life: A longitudinal home palliative care study. J Pain Symptom Manage. 2007 Apr;33(4):389–397. Accessed on January 01, 2021.
56.
HwangSSChangVTRueMKasimisB. Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003 Jul;26(1):604–614. Accessed on December 28, 2020.
57.
JacobsenPBHannDMAzzarelloLMHortonJBalducciLLymanGH. Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. J Pain Symptom Manage. 1999 Oct;18(4):233–242. doi: 10.1016/s0885-3924(99)00082-2. Accessed on January 01, 2021.
58.
Jereczek-FossaBASantoroLAlterioD, et al.Fatigue during head-and-neck radiotherapy: Prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):403–415. Accessed on January 02, 2021.
59.
JordanKProskorovskyILewisP, et al.Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: Results of a European, multicenter cohort study. Support Care Cancer. 2014 Feb;22(2):417–426. Accessed on January 02, 2021.
60.
KhosraviMTaghvaye MasoumiHGholamiKVaeziMHadjibabaeiMGhavamzadehA. The relationship between fatigue and cytokine levels in patients with acute myeloid leukemia. Int J Hematol Oncol Stem Cell Res. 2018 Oct 1;12(4):318–321. Accessed on December 26, 2020.
61.
KnobelHLogeJHNordøyT,et al.High level of fatigue in lymphoma patients treated with high dose therapy. J Pain Symptom Manage. 2000 Jun;19(6):446–456. Accessed on December 29, 2020.
62.
KurzKFieglMHolznerB, et al.Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown. PLoS One. 2012;7(5):e36956. Accessed on January 02, 2021.
63.
LacourtTEKavelaarsAOhanianM, et al.Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia. Oncotarget. 2018 Jul 27;9(58):31244–31252. Accessed on January 01, 2021.
64.
LatvalaASyrjänenKSalmenojaHSalminenE. Anaemia and other predictors of fatigue among patients on palliative therapy for advanced cancer. Anticancer Res. 2009 Jul;29(7):2569–2575. Accessed on December 28, 2020.
65.
LeeYLinPYLinMC, et al.Morbidity and associated factors of depressive disorder in patients with lung cancer. Cancer Manag Res. 2019 Aug 9;11:7587–7596. Accessed on January 01, 2021.
66.
LiLChanSLMoF, et al.Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma. Cancer Manag Res. 2019 Apr 4;11:2719–2727. Accessed on December 28, 2020.
67.
do Nascimento Santos LimaEFerreiraIBLajoloPPPaivaCEde Paiva MaiaYCdas Graças PenaG. Health-related quality of life became worse in short-term during treatment in head and neck cancer patients: A prospective study. Health Qual Life Outcomes. 2020 Sep 16;18(1):307. Accessed on December 27, 2020.
68.
MallinsonTCellaDCashyJHolznerB. Giving meaning to measure: Linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage. 2006 Mar;31(3):229–241. Accessed on December 28, 2020.
69.
MarinhoEDCCustódioIDDFerreiraIBCrispimCAPaivaCEMaiaYCP. Relationship between food perceptions and health-related quality of life in a prospective study with breast cancer patients undergoing chemotherapy. Clinics (Sao Paulo). 2018 Nov 29;73:e411. Accessed on January 01, 2021.
70.
MeyerhardtJASloanJASargentDJ, et al.Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1402–1410. Accessed on December 26, 2020.
71.
MiaskowskiCCooperBAPaulSM, et al.Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: A cluster analysis. Oncol Nurs Forum. 2006 Sep 1;33(5):E79–E89. Accessed on December 27, 2020.
72.
MiaskowskiCDoddMLeeK, et al.Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage. 2010 Oct;40(4):531–544. Accessed on January 02, 2021.
73.
OeiSLThronickeAKrözMvon TrottPSchadFMatthesH. Impact of oncological therapy and Viscum album L treatment on cancer-related fatigue and internal coherence in nonmetastasized breast cancer patients. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420917211. Accessed on December 28, 2020.
74.
PaniFMassiddaMPuscedduV, et al.Regorafenib-induced hypothyroidism and cancer-related fatigue: Is there a potential link?Eur J Endocrinol. 2017 Jul;177(1):85–92. doi: 10.1530/EJE-17-0231. Accessed on January 01, 2021.
75.
ParveenKNSinhaAPGargRDeoSVSKumarS. Fatigue and functional ability in patients undergoing upfront surgical treatment for solid malignancies. Indian J Surg Oncol. 2019 Sep;10(3):441–445. Accessed on January 01, 2021.
76.
PaulsenØLairdBAassN, et al.The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS One. 2017 May 25;12(5):e0177620. Accessed on December 26, 2020.
77.
ReidunsdatterRJRannestadTFrengenJFrykholmGLundgrenS. Early effects of contemporary breast radiation on health-related quality of life - predictors of radiotherapy-related fatigue. Acta Oncol. 2011 Nov;50(8):1175–1182. Accessed on January 02, 2021.
78.
ReidunsdatterRJAlbrektsenGHjermstadMJRannestadTOldervollLMLundgrenS. One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients--comparison to general population. Acta Oncol. 2013 Feb;52(2):239–248. Accessed on December 27, 2020.
79.
RenovanzMHickmannAKNadji-OhlM, et al.Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma-results of a multicenter study. Support Care Cancer. 2020 Nov;28(11):5165–5175. Accessed on December 28, 2020.
80.
RepkaCPHaywardR. Effects of an exercise intervention on cancer-related fatigue and its relationship to markers of oxidative stress. Integr Cancer Ther. 2018 Jun;17(2):503–510. Accessed on December 30, 2020.
81.
Reyes-GibbyCCWangJSpitzMWuXYennurajalingamSSheteS. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013 Aug;46(2):161–172. Accessed on December 27, 2020.
82.
RichTInnominatoPFBoernerJ, et al.Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-h rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 2005 Mar 1;11(5):1757–1764. Accessed on January 01, 2021.
83.
RichTZhaoFCrucianiRACellaDManolaJFischMJ. Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: A correlative study of a placebo-controlled fatigue trial. Cancer Manag Res. 2017 Jan 31;9:1–10. Accessed on January 02, 2021.
84.
RohSYYeomHALeeMAHwangIY. Mobility of older palliative care patients with advanced cancer: A Korean study. Eur J Oncol Nurs. 2014 Dec;18(6):613–618. Accessed on January 01, 2021.
85.
De SanctisVAgolliLViscoV, et al.Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy. Biomed Res Int. 2014;2014:523568. Accessed on December 26, 2020.
86.
ScheiSSolheimOJakolaASSagbergLM. Perioperative fatigue in patients with diffuse glioma. J Neurooncol. 2020 Mar;147(1):97–107. Accessed on December 29, 2020.
87.
SchvartsmanGParkMLiuDDYennuSBrueraEHuiD. Could objective tests be used to measure fatigue in patients with advanced cancer?J Pain Symptom Manage. 2017 Aug;54(2):237–244. Accessed on January 01, 2021.
88.
ShaFZhuangSZhouL, et al.Biomarkers for cancer-related fatigue and adverse reactions to chemotherapy in lung cancer patients. Mol Clin Oncol. 2015 Jan;3(1):163–166. Accessed on January 02, 2021.
89.
SingerSKuhntSZwerenzR, et al.Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer. 2011 Jul 26;105(3):445–451. Accessed on January 01, 2021.
90.
SinghPSAggarwalANBeheraDKapoorRSinghN. Simplified graded baseline symptom assessment in patients with lung cancer undergoing first-line chemotherapy: Correlations and prognostic role in a resource-constrained setting. J Glob Oncol. 2016 May 11;3(1):54–63. Accessed on January 02, 2021.
91.
SmetsEMGarssenBCullAde HaesJC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996 Jan;73(2):241–245. Accessed on December 28, 2020.
92.
SørensenHLSchjølbergTKSmåstuenMCUtneI. Social support in early-stage breast cancer patients with fatigue. BMC Womens Health. 2020 Oct 29;20(1):243. Accessed on January 02, 2021.
93.
SpichigerEMüller-FröhlichCDenhaerynckKStollHHantikainenVDoddM. Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy. Swiss Med Wkly. 2011 Nov 8;141(w13303), Accessed on December 27, 2020.
94.
StonePHardyJBroadleyKTookmanAJKurowskaAA'HernR. Fatigue in advanced cancer: A prospective controlled cross-sectional study. Br J Cancer. 1999 Mar;79(9-10):1479–1486. Accessed on December 30, 2020.
95.
StruikKKleinMHeimansJJ, et al.Fatigue in low-grade glioma. J Neurooncol. 2009 Mar;92(1):73–78. Accessed on January 01, 2021.
96.
TraegerLBraunIMGreerJATemelJSCashavellyBPirlWF. Parsing depression from fatigue in patients with cancer using the fatigue symptom inventory. J Pain Symptom Manage. 2011 Jul;42(1):52–59. Accessed on January 01, 2021.
97.
ValkoPOSiddiqueALinsenmeierCZauggKHeldUHoferS. Prevalence and predictors of fatigue in glioblastoma: A prospective study. Neuro Oncol. 2015 Feb;17(2):274–281. Accessed on January 01, 2021.
98.
VissersPAThongMSPouwerFCreemersGJSlooterGDvan de Poll-FranseLV. Prospectively measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes. Support Care Cancer. 2016 Jun;24(6):2591–2601. Accessed on December 26, 2020.
99.
HenryDHViswanathanHNElkinEPTrainaSWadeSCellaD. Symptoms and treatment burden associated with cancer treatment: Results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008 Jul;16(7):791–801. Accessed on December 26, 2020.
100.
WallingAMKeatingNLKahnKL, et al.Lower patient ratings of physician communication are associated with unmet need for symptom management in patients with lung and colorectal cancer. J Oncol Pract. 2016 Jun;12(6):e654–e669. Accessed on December 29, 2020.
101.
WangXSShiQShahND, et al.Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014 Mar 1;20(5):1366–1374. Accessed on December 30, 2020.
102.
BartschHHWeisJMoserMT. Cancer-related fatigue in patients attending oncological rehabilitation programs: Prevalence, patterns and predictors. Onkologie. 2003 Feb;26(1):51–57. Accessed on January 01, 2021.
103.
YennuSUrbauerDLBrueraE. Factors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic. BMC Palliat Care. 2012 Sep 17;11(16). Accessed on December 29, 2020.
104.
YennurajalingamSTayjasanantSBalachandranD, et al.Association between daytime activity, fatigue, sleep, anxiety, depression, and symptom burden in advanced cancer patients: A preliminary report. J Palliat Med. 2016 Aug;19(8):849–856. Accessed on January 02, 2021.
105.
MaYHeBJiangM,et al.Prevalence and risk factors of cancer-related fatigue: A systematic review and meta-analysis. Int J Nurs Stud. 2020 Nov;111:103707. Accessed on September 30, 2021.
